Alliance Boots buys 12% stake in Nanjing Pharmaceuticals

The UK retailer and wholesaler of drugs and beauty products is paying $91 million for the stake and will also form a strategic alliance with the Shanghai-listed firm.
<div style="text-align: left;">
The UK's leading pharmacist is joining hands in China
</div>
<div style="text-align: left;"> The UK's leading pharmacist is joining hands in China </div>

In a move that will further expand its footprint in China, Alliance Boots has agreed to pay approximately 56 million $91 million for a 12% stake in Shanghai-listed Nanjing Pharmaceutical. The two firms will also form a strategic alliance.

As a result of the investment, the UK pharmaceutical, healthcare and beauty product retailer will become the second-biggest shareholder in Nanjing Pharma, which is the fifth-largest wholesaler of pharmaceutical products in China. The UK company will get a seat on the board, as well as a role in the operational management.

“The cooperation with Alliance Boots is of great significance in the context of the slowing global economy...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222